Pre-Vent Apnea
Pre-Vent Apnea
批准号:
9168075
负责人:
Namasivayam Ambalavanan
金额:
$19.53万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-22 至 2021-06-30
关键词:
2 year oldAcuteAddressAdmission activityAgeAlabamaApneaBeginning of LifeBirthBloodBradycardiaBreathingBronchopulmonary DysplasiaCannulasCardiacChildChild health careChronicClinical ResearchData CollectionData Coordinating CenterDatabasesDevelopmentDiagnosisDoctor of PhilosophyDropsEligibility DeterminationEnrollmentEnvironmentEvaluationFutureGeneric DrugsGeneticGoalsHeart RateHourHydrocortisoneHypercapniaHypoxemiaIncubatorsIndividualInfantLeadershipMagnetic Resonance ImagingMassachusettsMaternal-Fetal Medicine Units NetworkMethodsMonitorMorbidity - disease rateMulticenter Neonatal Research NetworkNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Intensive Care UnitsNeonatologyNoseObservational StudyOutcomeOxygenPathogenesisPatternPerformancePhysiologic MonitoringPhysiologicalPolysomnographyPopulationPregnancyPremature InfantPrevention strategyProtocols documentationPulmonary HypertensionPulse OximetryRandomized Controlled TrialsResearchResearch PersonnelRespiration DisordersRiskRoleSchool-Age PopulationSignal TransductionSiteSleepSystemTechniquesTimeTranslational ResearchUniversitiesValidationVery Low Birth Weight InfantWeaningWomanbaseclinical research sitecohortfeedingfollow-upimprovedimproved outcomeindustry partnerinnovationinsightmathematical modelmedical schoolsmeetingsmemberpostnatalprematureprospectiveresearch clinical testingresiliencerespiratoryresponsesignal processingtechnology developmenttreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This “Pre-Vent Apnea” application brings together established investigators at the University of
Alabama at Birmingham (UAB; Clinical Site) with expertise in neonatal clinical and translational research
and at the University of Massachusetts Medical School (UMASS; Analytical Core) with complementary
expertise in control of breathing and signal processing in physiological systems. The overall objective of the
local project is to use a prospective cohort of 200 preterm infants <29 weeks gestation at UAB to
prospectively define and validate ventilatory mechanisms associated with resilience against or risk for
development of impaired oxygenation at 36 weeks' postmenstrual age (physiologic definition of BPD) and at
follow-up (corrected age of 3 months) using multiparametric physiologic monitoring and intensive data
collection (96 hours each) at three distinct time frames: 2 weeks postnatal age, 32 weeks post-menstrual
age (PMA), 36 weeks PMA, in addition to continuous heart rate, respiratory rate, and pulse oximetry
waveform recording from enrollment soon after birth until discharge.
We will address the objective by the following Specific Aims:
Specific Aim 1- Development and validation of mathematical models of personalized ventilatory patterns
based on multiparametric vital signs monitoring and signal analysis methods to (a) predict hypoxemic and/or
bradycardic episodes in individual infants before they occur, (b) identify patterns of ventilatory abnormalities
associated with BPD with and without pulmonary hypertension, as well as with and without respiratory or
feeding support at 3 months corrected age.
Specific Aim 2 - Determine if late (at or beyond postnatal day 14) mild permissive hypercapnia is associated
with reduction in apnea, bradycardia, and hypoxemic episodes and with improved stability of oxygenation.
Specific Aim 3 – Determine if servo-controlled oxygen environment is associated with reduction in
hypoxemic episodes and improved stability of oxygenation, as compared to oxygen administered by nasal
cannula.
In addition, for the multicenter collaborative project, we will collaborate with other clinical research
centers and a Leadership and Data Coordinating Center (LDCC) on a multicenter protocol that will
investigate ventilatory control mechanisms in outcomes of instability of oxygenation and acute and chronic
morbidity.
The ultimate goal of our participation in this project is to gain greater insight into the pathogenesis of
respiratory disorders in extremely preterm infants and discover targets for new prevention and treatment
strategies to improve outcomes for very vulnerable children at the beginning of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Let-7b in BPD
-
批准号:10655734
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
-
批准号:10576754
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10493363
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10891299
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
-
批准号:10363406
-
项目类别:
-
资助金额:$148.56万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10372486
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10360908
-
项目类别:
-
资助金额:$51.99万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
-
批准号:10541156
-
项目类别:
-
资助金额:$152.13万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Acute Renal Injury Sequelae in NICU Graduates (ARISING)
-
批准号:9899244
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2019
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:10006023
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:9762173
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9292368
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9143795
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:8996355
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:9062496
-
项目类别:
-
资助金额:$73.48万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8685690
-
项目类别:
-
资助金额:$74.01万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8870421
-
项目类别:
-
资助金额:$73.5万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8240026
-
项目类别:
-
资助金额:$59.75万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8610334
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8015539
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
海外基金